Ofatumumab versus Teriflunomide in Multiple Sclerosis. Hauser SL, Bar-Or A, Cohen JA, Comi G, et al. N Engl J Med 2020;383:546-557.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hauser SL, Bar-Or A, Cohen JA, Comi G, et al. Ofatumumab versus Teriflunomide in Multiple Sclerosis. N Engl J Med 2020;383:546-557.
PMID: 32757523